tedizolid phosphate 200 MG Oral Tablet

RxCUI
1540862
RxNorm name
tedizolid phosphate 200 MG Oral Tablet
Display name
tedizolid phosphate 200 MG Oral Tablet
Full name
tedizolid phosphate 200 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SIVEXTROTEDIZOLID PHOSPHATEMerck Sharp & Dohme LLC75672079-589f-451a-bdbf-eaebcfcc80a92026-02-27Warnings, Adverse reactionsExact identifier
rxcui: 1540862

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
75672079-589f-451a-bdbf-eaebcfcc80a9tedizolid phosphate 200 MG Oral Tablet [PSN] · tedizolid phosphate 200 MG Oral Tablet [SCD]234These highlights do not include all the information needed to use SIVEXTRO ® safely and effectively. See full prescribing information for SIVEXTRO. SIVEXTRO (tedizolid phosphate) for injection, for intravenous use SIVEXTRO (tedizolid phosphate) tablet, for oral use Initial U.S. Approval: 201420260227
11d5c110-c48c-438f-9c7d-5adf99938534tedizolid phosphate 200 MG Oral Tablet [PSN] · tedizolid phosphate 200 MG Oral Tablet [SCD]27These highlights do not include all the information needed to use SIVEXTRO ® safely and effectively. See full prescribing information for SIVEXTRO. SIVEXTRO ® (tedizolid phosphate) for injection, for intravenous use SIVEXTRO ® (tedizolid phosphate) tablet, for oral use Initial U.S. Approval: 201420241114